These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 2702102

  • 1. Treatment of severe IgA nephropathy in children.
    Andreoli SP, Bergstein JM.
    Pediatr Nephrol; 1989 Jul; 3(3):248-53. PubMed ID: 2702102
    [Abstract] [Full Text] [Related]

  • 2. IgA nephropathy in children: significance of glomerular basement membrane deposition of IgA.
    Andreoli SP, Yum MN, Bergstein JM.
    Am J Nephrol; 1986 Jul; 6(1):28-33. PubMed ID: 3515942
    [Abstract] [Full Text] [Related]

  • 3. [Clinicopathological analysis of IgA nephropathy with crescentic formation in childhood].
    Yao Y, Liu JC, Xiao HJ, Huang JP, Yang JY.
    Zhonghua Er Ke Za Zhi; 2004 Jun; 42(6):412-6. PubMed ID: 15265422
    [Abstract] [Full Text] [Related]

  • 4. A validation study of crescents in predicting ESRD in patients with IgA nephropathy.
    Zhang X, Shi S, Ouyang Y, Yang M, Shi M, Pan X, Lv J, Wang Z, Ren H, Shen P, Wang W, Zhang H, Xie J, Chen N.
    J Transl Med; 2018 May 03; 16(1):115. PubMed ID: 29724226
    [Abstract] [Full Text] [Related]

  • 5. Comprehensive evaluation of the significance of immunofluorescent findings on clinicopathological features in IgA nephropathy.
    Katafuchi R, Nagae H, Masutani K, Tsuruya K, Mitsuiki K.
    Clin Exp Nephrol; 2019 Feb 03; 23(2):169-181. PubMed ID: 30066158
    [Abstract] [Full Text] [Related]

  • 6. Can immunosuppressive drugs slow the progression of IgA nephropathy?
    Goumenos D, Ahuja M, Shortland JR, Brown CB.
    Nephrol Dial Transplant; 1995 Feb 03; 10(7):1173-81. PubMed ID: 7478120
    [Abstract] [Full Text] [Related]

  • 7. A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. The Japanese Pediatric IgA Nephropathy Treatment Study Group.
    Yoshikawa N, Ito H, Sakai T, Takekoshi Y, Honda M, Awazu M, Ito K, Iitaka K, Koitabashi Y, Yamaoka K, Nakagawa K, Nakamura H, Matsuyama S, Seino Y, Takeda N, Hattori S, Ninomiya M.
    J Am Soc Nephrol; 1999 Jan 03; 10(1):101-9. PubMed ID: 9890315
    [Abstract] [Full Text] [Related]

  • 8. IgA nephropathy with severe chronic renal failure: a randomized controlled trial of corticosteroids and azathioprine.
    Pozzi C, Andrulli S, Pani A, Scaini P, Roccatello D, Fogazzi G, Pecchini P, Rustichelli R, Finocchiaro P, Del Vecchio L, Locatelli F.
    J Nephrol; 2013 Jan 03; 26(1):86-93. PubMed ID: 22460183
    [Abstract] [Full Text] [Related]

  • 9. [Evaluation of prednisone treatment in children with IgA nephropathy and Schönlein-Henoch nephropathy according to the Waldo protocol with regard to pathomorphologic changes in renal biopsy].
    Szymanik-Grzelak H, Mizerska-Wasiak M, Roszkowska-Blaim M.
    Pol Merkur Lekarski; 2001 Apr 03; 10(58):259-62. PubMed ID: 11434171
    [Abstract] [Full Text] [Related]

  • 10. Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort.
    Coppo R, Lofaro D, Camilla RR, Bellur S, Cattran D, Cook HT, Roberts IS, Peruzzi L, Amore A, Emma F, Fuiano L, Berg U, Topaloglu R, Bilginer Y, Gesualdo L, Polci R, Mizerska-Wasiak M, Caliskan Y, Lundberg S, Cancarini G, Geddes C, Wetzels J, Wiecek A, Durlik M, Cusinato S, Rollino C, Maggio M, Praga M, K Smerud H, Tesar V, Maixnerova D, Barratt J, Papalia T, Bonofiglio R, Mazzucco G, Giannakakis C, Soderberg M, Orhan D, Di Palma AM, Maldyk J, Ozluk Y, Sudelin B, Tardanico R, Kipgen D, Steenbergen E, Karkoszka H, Perkowska-Ptasinska A, Ferrario F, Gutierrez E, Honsova E.
    Pediatr Nephrol; 2017 Jan 03; 32(1):139-150. PubMed ID: 27557557
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of methylprednisolone, cyclophosphamide in pediatric IgA nephropathy assessed by renal biopsy.
    Jiang XY, Mo Y, Sun LZ, Yue ZH, Chen SM, Wu W.
    Clin Nephrol; 2009 Jun 03; 71(6):625-31. PubMed ID: 19473630
    [Abstract] [Full Text] [Related]

  • 12. IgA Nephropathy in Children: A Multicenter Study in Poland.
    Mizerska-Wasiak M, Turczyn A, Such A, Cichoń-Kawa K, Małdyk J, Miklaszewska M, Pietrzyk J, Rybi-Szumińska A, Wasilewska A, Firszt-Adamczyk A, Stankiewicz R, Szczepańska M, Bieniaś B, Zajączkowska M, Pukajło-Marczyk A, Zwolińska D, Siniewicz-Luzeńczyk K, Tkaczyk M, Gadomska-Prokop K, Grenda R, Demkow U, Pańczyk-Tomaszewska M.
    Adv Exp Med Biol; 2016 Jun 03; 952():75-84. PubMed ID: 27573641
    [Abstract] [Full Text] [Related]

  • 13. A clinicopathological study of IgA nephropathy in renal transplant recipients: beneficial effect of angiotensin-converting enzyme inhibitor.
    Oka K, Imai E, Moriyama T, Akagi Y, Ando A, Hori M, Okuyama A, Toki K, Kyo M, Kokado Y, Takahara S.
    Nephrol Dial Transplant; 2000 May 03; 15(5):689-95. PubMed ID: 10809812
    [Abstract] [Full Text] [Related]

  • 14. Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group.
    Trimarchi H, Barratt J, Cattran DC, Cook HT, Coppo R, Haas M, Liu ZH, Roberts IS, Yuzawa Y, Zhang H, Feehally J, IgAN Classification Working Group of the International IgA Nephropathy Network and the Renal Pathology SocietyHospital Británico de Buenos Aires, Argentina., Conference Participants.
    Kidney Int; 2017 May 03; 91(5):1014-1021. PubMed ID: 28341274
    [Abstract] [Full Text] [Related]

  • 15. Chronicity index and mesangial IgG deposition are risk factors for hypertension and renal failure in early IgA nephropathy.
    Nieuwhof C, Kruytzer M, Frederiks P, van Breda Vriesman PJ.
    Am J Kidney Dis; 1998 Jun 03; 31(6):962-70. PubMed ID: 9631840
    [Abstract] [Full Text] [Related]

  • 16. [Clinical and pathological analysis of IgA nephropathy with acute kidney injury].
    Chen MG, Ye XH, Liang HY, Yang Q.
    Zhonghua Er Ke Za Zhi; 2016 Aug 03; 54(8):610-3. PubMed ID: 27510875
    [Abstract] [Full Text] [Related]

  • 17. Value of the Oxford classification of IgA nephropathy in children with Henoch-Schönlein purpura nephritis.
    Xu K, Zhang L, Ding J, Wang S, Su B, Xiao H, Wang F, Zhong X, Li Y.
    J Nephrol; 2018 Apr 03; 31(2):279-286. PubMed ID: 29185209
    [Abstract] [Full Text] [Related]

  • 18. Alternate-day prednisone therapy in children with IgA-associated nephritis.
    Waldo FB, Alexander R, Wyatt RJ, Kohaut EC.
    Am J Kidney Dis; 1989 Jan 03; 13(1):55-60. PubMed ID: 2912065
    [Abstract] [Full Text] [Related]

  • 19. Prognostic indicators in childhood IgA nephropathy.
    Yoshikawa N, Ito H, Nakamura H.
    Nephron; 1992 Jan 03; 60(1):60-7. PubMed ID: 1738416
    [Abstract] [Full Text] [Related]

  • 20. Disappearance of glomerular IgA deposits in childhood IgA nephropathy showing diffuse mesangial proliferation after 2 years of combination/prednisolone therapy.
    Shima Y, Nakanishi K, Kamei K, Togawa H, Nozu K, Tanaka R, Sasaki S, Iijima K, Yoshikawa N.
    Nephrol Dial Transplant; 2011 Jan 03; 26(1):163-9. PubMed ID: 20601366
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.